This podcast episode explores Uber's financial performance and valuation, contrasting business models and investment strategies of Uber and Pfizer, investment potential in pharmaceutical companies, the trend of startup founders being guilty of fraud, predictions for the "New Normal" after the pandemic, and the need for individuals to plan for a longer retirement.
